Cargando…
The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes
BACKGROUND: The model-based dynamic insulin sensitivity and secretion test (DISST) uses fasting glucose (G(0)) as the basal glucose (G(B)) concentration when assessing insulin sensitivity (SI). However, this model was developed in a healthy, normoglycaemic cohort. We sought to determine the suitabil...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350631/ https://www.ncbi.nlm.nih.gov/pubmed/25881031 http://dx.doi.org/10.1186/s12938-015-0015-7 |
_version_ | 1782360211882770432 |
---|---|
author | Othman, Nor Azlan Docherty, Paul D Krebs, Jeremy D Bell, Damon A Chase, J Geoffrey |
author_facet | Othman, Nor Azlan Docherty, Paul D Krebs, Jeremy D Bell, Damon A Chase, J Geoffrey |
author_sort | Othman, Nor Azlan |
collection | PubMed |
description | BACKGROUND: The model-based dynamic insulin sensitivity and secretion test (DISST) uses fasting glucose (G(0)) as the basal glucose (G(B)) concentration when assessing insulin sensitivity (SI). However, this model was developed in a healthy, normoglycaemic cohort. We sought to determine the suitability the DISST model has for individuals with established type 2 diabetes (T2D). METHODS: 14 participants with established T2D were recruited to take part in a dietary intervention study. Insulin-modified intravenous glucose tolerance tests (IM-IVGTT) were undertaken at week 0, 12 and 24 and were used with DISST model to identify G(B). A total of 36 tests were conducted across 12 participants throughout the study. Measured G(0) and identified G(B) values were compared using a Kolmogorov-Smirnov (KS) and signed rank (RS) test for the cohort. RESULTS: There were significant differences between the G(0) and identified G(B) values in this cohort (p(rs) and p(ks) < 0.0001), although both values were well correlated (R = 0.70). The residual plot demonstrates that the modified model captures the behaviour of the participants more accurately than the original model. CONCLUSIONS: This analysis has shown that G(B) is an important variable for modelling the glycaemic behaviour in T2D. These findings suggest that the original DISST model, while appropriate for normoglycaemic cohorts, needs to model basal glucose level as a variable for assessing individuals with established T2D. |
format | Online Article Text |
id | pubmed-4350631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43506312015-03-06 The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes Othman, Nor Azlan Docherty, Paul D Krebs, Jeremy D Bell, Damon A Chase, J Geoffrey Biomed Eng Online Research BACKGROUND: The model-based dynamic insulin sensitivity and secretion test (DISST) uses fasting glucose (G(0)) as the basal glucose (G(B)) concentration when assessing insulin sensitivity (SI). However, this model was developed in a healthy, normoglycaemic cohort. We sought to determine the suitability the DISST model has for individuals with established type 2 diabetes (T2D). METHODS: 14 participants with established T2D were recruited to take part in a dietary intervention study. Insulin-modified intravenous glucose tolerance tests (IM-IVGTT) were undertaken at week 0, 12 and 24 and were used with DISST model to identify G(B). A total of 36 tests were conducted across 12 participants throughout the study. Measured G(0) and identified G(B) values were compared using a Kolmogorov-Smirnov (KS) and signed rank (RS) test for the cohort. RESULTS: There were significant differences between the G(0) and identified G(B) values in this cohort (p(rs) and p(ks) < 0.0001), although both values were well correlated (R = 0.70). The residual plot demonstrates that the modified model captures the behaviour of the participants more accurately than the original model. CONCLUSIONS: This analysis has shown that G(B) is an important variable for modelling the glycaemic behaviour in T2D. These findings suggest that the original DISST model, while appropriate for normoglycaemic cohorts, needs to model basal glucose level as a variable for assessing individuals with established T2D. BioMed Central 2015-03-03 /pmc/articles/PMC4350631/ /pubmed/25881031 http://dx.doi.org/10.1186/s12938-015-0015-7 Text en © Othman et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Othman, Nor Azlan Docherty, Paul D Krebs, Jeremy D Bell, Damon A Chase, J Geoffrey The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes |
title | The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes |
title_full | The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes |
title_fullStr | The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes |
title_full_unstemmed | The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes |
title_short | The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes |
title_sort | necessity of identifying the basal glucose set-point in the ivgtt for patients with type 2 diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350631/ https://www.ncbi.nlm.nih.gov/pubmed/25881031 http://dx.doi.org/10.1186/s12938-015-0015-7 |
work_keys_str_mv | AT othmannorazlan thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT dochertypauld thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT krebsjeremyd thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT belldamona thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT chasejgeoffrey thenecessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT othmannorazlan necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT dochertypauld necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT krebsjeremyd necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT belldamona necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes AT chasejgeoffrey necessityofidentifyingthebasalglucosesetpointintheivgttforpatientswithtype2diabetes |